Pharma Mar (FRA:PMRA) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


FRA:PMRA Pharma Mar SA FRA:PMRA
83 GF Score
Price €68.05
GF Value €83.37
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Pharma Mar's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FRA:PMRA vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Pharma Mar's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Mar Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Margin of Safety % (DCF FCF Based) falls into.


FRA:PMRA
83GF Score
Pharma Mar SA FRA:PMRA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharma Mar (FRA:PMRA) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of €68.05 is trading 18.4% below its estimated GF Value™ of €83.37. GuruFocus considers Pharma Mar to be Modestly Undervalued.

Key valuation signals for FRA:PMRA:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €83.37 vs. price of €68.05 (18.4% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the FRA:PMRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
83GF Score

Get the complete analysis for FRA:PMRA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.05
Price
€83.37
GF Value